Comparison between AGS Transact Technologies IPO and Medplus Health IPO.
AGS Transact Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Medplus Health IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of AGS Transact Technologies IPO is up to ₹680.00 Cr whereas the issue size of the Medplus Health IPO is up to ₹1,398.29 Cr. The final issue price of AGS Transact Technologies IPO is ₹175.00 per share and of Medplus Health IPO is ₹796.00 per share.
| AGS Transact Technologies IPO | Medplus Health IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹166.00 per share | ₹780.00 per share |
| Issue Price (Upper) | ₹175.00 per share | ₹796.00 per share |
| Issue Price (Final) | ₹175.00 per share | ₹796.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹78.00 per share | |
| Market Lot Size | 85 shares | 18 shares |
| Fresh Issue Size | 0 shares | 75,44,511 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹600.31 Cr |
| OFS Issue Size | 3,88,57,141 shares | 1,00,28,831 shares |
| OFS Issue Size (Amount) | up to ₹680.00 Cr | up to ₹797.98 Cr |
| Issue Size Total | 3,88,57,141 shares | 1,75,73,342 shares |
| Issue Size Total (Amount) | up to ₹680.00 Cr | up to ₹1,398.29 Cr |
AGS Transact Technologies IPO opens on Jan 19, 2022, while Medplus Health IPO opens on Dec 13, 2021. The closing date of AGS Transact Technologies IPO and Medplus Health IPO is Jan 21, 2022, and Dec 15, 2021, respectively.
| AGS Transact Technologies IPO | Medplus Health IPO | |
|---|---|---|
| Anchor Bid Date | Jan 18, 2022 | Dec 10, 2021 |
| Issue Open | Jan 19, 2022 | Dec 13, 2021 |
| Issue Close | Jan 21, 2022 | Dec 15, 2021 |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | Dec 20, 2021 |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | Dec 21, 2021 |
| Credit of Share (Tentative) | Jan 31, 2022 | Dec 22, 2021 |
| Listing date (Tentative) | Jan 31, 2022 | Dec 23, 2021 |
| Anchor Lockin End date 1 | Feb 26, 2022 | Jan 19, 2022 |
| Anchor Lockin End date 2 | Apr 27, 2022 | Mar 20, 2022 |
AGS Transact Technologies IPO P/E ratio is , as compared to Medplus Health IPO P/E ratio of .
| AGS Transact Technologies IPO | Medplus Health IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 98.23 | 43.16 | ||||
| Promoter Shareholding (Post-Issue) | 66.07 | 40.43 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2106.87 Cr. | ₹9496.73 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ₹4.62 | |||||
| RoNW | 10.29 |
In the AGS Transact Technologies IPO Retail Individual Investors (RII) are offered 1,36,00,000 shares while in Medplus Health IPO retail investors are offered 1,36,00,000 shares. Qualified Institutional Buyers (QIB) are offered 77,71,428 shares in AGS Transact Technologies IPO and 35,00,741 shares in Medplus Health IPO.
| AGS Transact Technologies IPO | Medplus Health IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,16,57,141 shares | 52,51,111 shares |
| Market Maker Reservation | ||
| QIB | 77,71,428 shares | 35,00,741 shares |
| NII | 58,28,572 shares | 26,25,556 shares |
| RII | 1,36,00,000 shares | 61,26,297 shares |
| Employee | 69,637 shares | |
| Others | ||
| Total | 3,88,57,141 shares | 1,75,73,342 shares |
AGS Transact Technologies IPO subscribed 7.79x in total, whereas Medplus Health IPO subscribed 52.59x.
| AGS Transact Technologies IPO | Medplus Health IPO | |
|---|---|---|
| QIB (times) | 2.68x | 111.90x |
| NII (times) | 25.61x | 85.33x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.08x | 5.24x |
| Employee (times) | 3.05x | |
| Other (times) | ||
| Total (times) | 7.79x | 52.59x |
